Hot Pursuit     01-Dec-23
Biocon Ltd up for third consecutive session
Biocon Ltd is quoting at Rs 241.25, up 1.24% on the day as on 12:49 IST on the NSE. The stock is down 14.92% in last one year as compared to a 8.45% jump in NIFTY and a 24.4% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 241.25, up 1.24% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.71% on the day, quoting at 20276.75. The Sensex is at 67486.34, up 0.74%. Biocon Ltd has gained around 8.79% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has gained around 9.75% in last one month and is currently quoting at 16238.9, up 0.25% on the day. The volume in the stock stood at 22.54 lakh shares today, compared to the daily average of 30.68 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 242.6, up 1% on the day. Biocon Ltd is down 14.92% in last one year as compared to a 8.45% jump in NIFTY and a 24.4% jump in the Nifty Pharma index.

The PE of the stock is 476.9 based on TTM earnings ending September 23.

Previous News
  Biocon Ltd spurts 1.07%, gains for fifth straight session
 ( Hot Pursuit - 03-Jul-25   13:00 )
  Nifty above 25,550 mark; oil & gas shares jump
 ( Market Commentary - Mid-Session 03-Jul-25   10:39 )
  Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars
 ( Hot Pursuit - 03-Jul-25   09:50 )
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
 ( Corporate News - 03-Jul-25   09:12 )
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
Other Stories
  V2 Retail’s revenue climbs 51% YoY in Q1 FY26
  03-Jul-25   15:14
  Arkade Developers surges after acquiring Goregaon-based redevelopment project
  03-Jul-25   15:07
  VST Industries Ltd leads losers in 'A' group
  03-Jul-25   15:00
  CARE Ratings reaffirms ratings of India Shelter Finance at 'CARE AA-' with 'stable’' outlook
  03-Jul-25   14:56
  U. Y. Fincorp Ltd leads losers in 'B' group
  03-Jul-25   14:45
  Bajel Projects hits the roof after securing mega order from Power Grid Corporation
  03-Jul-25   14:41
  Volumes soar at DCM Shriram Ltd counter
  03-Jul-25   14:30
  REC Ltd down for fifth straight session
  03-Jul-25   13:35
  Persistent Systems appoints Shimona Chadha as CMO
  03-Jul-25   13:19
  Maruti Suzuki India Ltd gains for third straight session
  03-Jul-25   13:05
Back Top